Loading
Latest filing published 12 Mar 2026 for 비보존 제약, €2,332. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 박상성 in 비보존 제약, where the filings describe the role as chief executive. Between 30 January 2026 and 5 March 2026, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 2 purchases, €2,332 in total. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 12 March 2026, the filings show an open-market purchase worth €2,332 in 비보존 제약. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.